The anti-neoplastic agents market is influenced by continuing efforts to develop effective medicines for different types of cancer. Pharmaceutical companies are investigating new therapeutic mechanisms, improving existing treatments, and expanding clinical research across oncology indications. By 2034, treatment personalization, safety monitoring, and advances in cancer biology are expected to...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek